EGFR and non-small cell lung carcinoma: 34249454 34249454 Qiu X, Wang Y, Liu F et al (2021) Survival and prognosis analyses of concurrent PIK3CA mutations in EGFR mutant non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.